Therapeutic Science and Strategy

Pharma portfolios can create powerful opportunities, but without clear positioning, brands can end up competing with each other.

In this episode, Lumanity's Jakub Kaczor, VP, Strategy Consulting, and Peter Smith, SVP, Strategy Consulting, discuss the complexities of portfolio positioning in the pharmaceutical industry. The guests explain that while a focused R&D strategy drives commercial growth and sustained innovation, it also creates a paradox where a company's own assets can end up competing against each other in the same disease area. To mitigate internal rivalry and maximize commercial potential, they advise companies to begin co-positioning early and follow a structured planning process, grounded in market reality. Ultimately, achieving portfolio success requires overcoming brand egos through a collaborative mindset, establishing clear governance under a dedicated portfolio owner, and designing strategies that anticipate the future competitive landscape.

Tune in to learn how pharma teams can reduce internal competition, improve customer clarity, and build stronger portfolios that serve both patients and commercial goals!

Resources:

• Connect with and follow Jakub Kaczor on LinkedIn.

• Connect with and follow Peter Smith on LinkedIn.

• Follow Lumanity on LinkedIn and explore our website!

In the volatility caused by policy convergence, the future belongs to organizations that can intelligently navigate inflection points that precede launch

In this episode, Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity discusses how policy shifts are converging to compress pharma revenue opportunity and force decisive commercial choices much earlier in development. He highlights how IRA time horizons, Europe's Joint Clinical Assessment, and MFN cross-border pricing dynamics are creating downstream constraints that multiply when they hit together making "best science" and "commercial excellence" alone insufficient. The new reality is that value is won or lost at a small number of irreversible decision points, so companies must move commercial thinking upstream into target selection, indication sequencing, evidence planning, protocol design, pricing architecture, and market entry strategy. Steve talks through four inflection points - early path-to-value, optimal development strategy, go-to-market configuration, and sustained value reinforcement - to help leaders anticipate evidence demands, plan for scenarios, and build value into assets before it's too late to fix later.

Tune in to hear how the future of value creation is being reshaped, and why companies that prepare earlier will have a major strategic advantage!

Resources:

• Connect with and follow Steve Mather on LinkedIn.

• Follow Lumanity on LinkedIn and explore their website!

• Learn more about this series we're doing with Lumanity here: https://lumanity.com/commercialization-podcasts/

Most pharma launch frameworks don't fail because they lack structure; they fail because they become rigid checklists that kill strategic thinking.

In this episode, Lumanity's Launch Excellence Project Lead, Jeff Hart, and Launch Excellence Principal, Kirsty Tait, talk about how pharmaceutical companies can scale launch excellence as pipelines grow and complexity increases. Kirsty and Jeff explain that rigid, one-size-fits-all frameworks lead to inefficiency, slow decisions, and misalignment across global and local teams. Instead, organizations need a standardized operating system with built-in flexibility to tailor strategy by asset and market. Ultimately, success depends not just on process, but on strong governance, a single source of truth, and a winning culture that drives execution.

If your launch process feels slow, inconsistent, or overly complex, this conversation will help you rethink how to scale without losing speed or impact. Take a look at the Launch Excellence Health Check here!

Launching a pharma product is a high-stakes, pressure-filled marathon where poor planning shows up too late to fix. In this episode, Andrew Mooney and Laurence Cooper break down how early planning, focused strategy, and disciplined execution help smaller pharma teams succeed in high-pressure launches. If you're preparing for a first-time or early-stage pharma launch, this conversation breaks down exactly how to stay focused, avoid costly surprises, and execute with confidence!

Great pharma brands don't wait for the market to define them; they define themselves through clear, early, and evolving positioning.

In this episode, Vice President Natalie Thovmasian and Managing Consultant Liv Yates, highlight that brand positioning is a strategic driver across the entire pharma lifecycle, not just a launch activity. They stress the importance of shaping positioning early, before clinical data, by defining a bold vision through a target product profile and grounding it in customer needs and future market dynamics. Strong positioning acts as a mental shortcut, requiring clarity, differentiation, and emotional resonance to stand out amid overwhelming data. As markets evolve, positioning must be continuously assessed and refined to maintain relevance, consistency, and impact.

In the third episode of our Patient Progress podcast series, we look at the hidden and not-so-hidden barriers that keep marginalized communities from getting the mental and physical healthcare they need.

Advocates Sarah Renee and Daniel Newman join host Jenny Payne for a candid conversation about how cost, stigma, and institutional biasintersect to make care harder to reach—and how these obstacles affect both mental and physical health.

Through their lived experiences, Sarah Renee and Daniel reveal the human impact behind the statistics and share practical examples of programs and policies that are making a difference. They highlight where progress is happening and where much more needs to be done, offering hope and actionable ideas for change.

Listen now to hear their stories and explore how we can work together to close the health gap for good.

In Episode 2 of our Patient Progress podcast series, we hear directly from those living with mental illness about the obstacles they face: the cost of care, insurance hurdles, and the lack of consistent support services that can mean the difference between getting well and going without.

Advocates Kody Green and Gabe Howard share candid stories that reveal why access and affordability aren't just policy issues – they're human ones, affecting people across the spectrum of health needs.

Listen now and join the call for care that's equitable, compassionate, and within reach for all.

During this conversation with Outcomes Rocket, Sandy Richardson and Zoe Brown, Principals at Lumanity, talk about why organizations struggle to turn massive amounts of competitive intelligence into actionable strategy.

In part 2, Sandy and Zoe discuss how companies can move beyond information overload to build true competitive readiness through focus, collaboration, and action. They explain why real insight comes from asking the right questions, filtering out noise, and fostering ongoing, structured collaboration between global and local teams. The conversation highlights how scenario planning, simulations, and clear action plans help organizations prepare for uncertainty while staying anchored to their core strategy.

Tune in to learn how competitive readiness can become a living capability that helps your organization stay prepared, confident, and ahead of what's coming next!

During this conversation, Sandy Richardson and Zoe Brown, Principals at Lumanity, talk about why organizations struggle to turn massive amounts of competitive intelligence into actionable strategy.

In part 1, Sandy and Zoe explain how today's "sea of sameness" makes true differentiation harder than ever, and how teams often remain "data rich but time poor," missing early signals of competitive threats. They also break down how overreliance on clinical data, short planning cycles, and internal focus prevent companies from seeing the bigger picture and responding effectively.

Tune in to learn how competitive readiness can become a living capability that helps your organization stay prepared, confident, and ahead of what's coming next!

Caregivers are often the unsung heroes of healthcare: key decision‑makers, advocates, researchers, and emotional anchors. Yet, support for their own mental health is frequently absent. In this episode, Lumanity's Jenny Payne sits down with Ashlee Cramer and Ceinwen Giles to break misconceptions ("Caregivers are saints and happy to do it") and discuss the real impact — from anxiety, depression, and burnout to post‑traumatic growth (PTG). We explore how caregiving can mean sacrificing careers, social connections, and personal health, while also offering moments of deep human connection and perspective.